Assessing interactions for fixed-dose drug combinations in subcutaneous tumor xenograft studies

Area of Science:

• Pharmacology and Oncology
• Preclinical Cancer Research
• Drug Combination Studies

Background:

• Preclinical tumor xenograft studies frequently use fixed doses for drug combinations.
• Current methods for assessing the joint action of fixed-dose drug combinations are underdeveloped.
• There is a need for robust statistical approaches to evaluate drug synergy or antagonism in fixed-dose settings.

Purpose of the Study:

• To propose a novel interaction index for assessing drug combinations at fixed doses in subcutaneous tumor xenograft models.
• To develop a bootstrap percentile interval for this interaction index to provide confidence limits.
• To enable reliable assessment of the joint action of two drugs in preclinical cancer studies.

Main Methods:

• Development of a new interaction index specifically designed for fixed-dose drug combinations.
• Implementation of a bootstrap percentile interval method for calculating confidence limits of the interaction index.
• Application of the proposed method to analyze existing tumor xenograft data from two-drug combination studies.

Main Results:

• The proposed interaction index effectively quantifies the joint action of fixed-dose drug combinations.
• The bootstrap percentile interval provides statistically valid confidence limits for assessing drug interactions.
• Analysis of real-world xenograft data demonstrated the utility and applicability of the developed method.

Conclusions:

• The developed interaction index and bootstrap method offer a significant advancement in evaluating fixed-dose drug combinations in preclinical oncology.
• This approach allows for a more precise and reliable assessment of synergistic or antagonistic effects of drug combinations.
• The findings support the use of this method for better decision-making in drug development and combination therapy research.